Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0032991 | protein-containing complex | 1 | 4 |
GO:1990904 | ribonucleoprotein complex | 2 | 4 |
Related structures:
AlphaFold database: E9ALZ0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.282 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.223 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.294 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.440 |
CLV_PCSK_FUR_1 | 95 | 99 | PF00082 | 0.441 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.248 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.223 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.290 |
CLV_PCSK_KEX2_1 | 95 | 97 | PF00082 | 0.488 |
CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.237 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.202 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.541 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.557 |
DOC_CYCLIN_RxL_1 | 21 | 31 | PF00134 | 0.255 |
DOC_USP7_MATH_1 | 14 | 18 | PF00917 | 0.420 |
DOC_USP7_MATH_1 | 64 | 68 | PF00917 | 0.497 |
LIG_14-3-3_CanoR_1 | 106 | 111 | PF00244 | 0.448 |
LIG_14-3-3_CanoR_1 | 65 | 69 | PF00244 | 0.497 |
LIG_APCC_ABBA_1 | 52 | 57 | PF00400 | 0.402 |
LIG_BRCT_BRCA1_1 | 43 | 47 | PF00533 | 0.497 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.327 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.416 |
LIG_SH2_STAT3 | 29 | 32 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.343 |
MOD_CK2_1 | 15 | 21 | PF00069 | 0.412 |
MOD_Cter_Amidation | 74 | 77 | PF01082 | 0.217 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.414 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.447 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.437 |
MOD_NEK2_2 | 4 | 9 | PF00069 | 0.346 |
MOD_NEK2_2 | 64 | 69 | PF00069 | 0.503 |
MOD_PIKK_1 | 28 | 34 | PF00454 | 0.416 |
MOD_PKA_2 | 64 | 70 | PF00069 | 0.497 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.324 |
MOD_SUMO_rev_2 | 2 | 7 | PF00179 | 0.440 |
MOD_SUMO_rev_2 | 99 | 107 | PF00179 | 0.498 |
TRG_ER_diArg_1 | 22 | 24 | PF00400 | 0.322 |
TRG_ER_diArg_1 | 76 | 78 | PF00400 | 0.549 |
TRG_ER_diArg_1 | 95 | 98 | PF00400 | 0.443 |
TRG_NLS_Bipartite_1 | 95 | 109 | PF00514 | 0.581 |
TRG_NLS_MonoExtN_4 | 102 | 109 | PF00514 | 0.495 |
TRG_Pf-PMV_PEXEL_1 | 11 | 15 | PF00026 | 0.391 |
TRG_Pf-PMV_PEXEL_1 | 66 | 70 | PF00026 | 0.234 |
TRG_Pf-PMV_PEXEL_1 | 98 | 103 | PF00026 | 0.479 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IM99 | Leptomonas seymouri | 85% | 100% |
A0A0S4J2L5 | Bodo saltans | 53% | 79% |
A0A1X0NZM5 | Trypanosomatidae | 72% | 100% |
A0A3S7X280 | Leishmania donovani | 100% | 100% |
A0A422NRL3 | Trypanosoma rangeli | 70% | 100% |
A4HH94 | Leishmania braziliensis | 96% | 100% |
A4I4E0 | Leishmania infantum | 100% | 100% |
C9ZL22 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 77% | 97% |
E9ADU0 | Leishmania major | 99% | 100% |
Q7LL14 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 34% | 100% |